ASTRAZENECA PHARMA INDIA LTD. - 506820 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Change In Role Of Senior Management Personnel
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we would like to inform that our current Site Lead India Operations - Ms. Mina Patel is completing her international assignment on July 31, 2024. She will be transitioning from the said role with effect from close of business hours July 31, 2024, as she takes up another responsibility within AstraZeneca group. Further, we wish to inform that, based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company have approved the appointment of Mr. Srikanth B.S. as Site Lead, India Operations with effect from August 1, 2024.03-07-2024